ZIM Laboratories Limited (BOM:541400)
India · Delayed Price · Currency is INR 68.22
-0.36 (-0.52%)
At close: Mar 4, 2026
ZIM Laboratories Market Cap
ZIM Laboratories has a market cap or net worth of 3.3 billion as of March 5, 2026. Its market cap has decreased by -31.96% in one year.
Market Cap
3.30B
Enterprise Value
4.49B
Revenue
3.78B
Ranking
n/a
PE Ratio
47.23
Stock Price
68.22
Market Cap Chart
Since June 11, 2018, ZIM Laboratories's market cap has increased from 1.68B to 3.30B, an increase of 96.34%. That is a compound annual growth rate of 9.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 3.30B | -5.76% |
| Dec 31, 2025 | 3.50B | -33.11% |
| Dec 31, 2024 | 5.24B | -6.72% |
| Dec 29, 2023 | 5.62B | 18.57% |
| Dec 30, 2022 | 4.74B | 146.60% |
| Dec 31, 2021 | 1.92B | 31.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jenburkt Pharmaceuticals | 4.40B |
| Albert David | 3.92B |
| Medicamen Biotech | 3.78B |
| Medico Remedies | 3.54B |
| Amanta Healthcare | 3.44B |
| Trident Lifeline | 3.20B |
| Everest Organics | 2.88B |
| Gennex Laboratories | 2.67B |